APA (7th ed.) Citation

CE, A., MI, N., T, H., AS, M., T, T., NK, M., . . . PR, L. (2015). NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer. BMC cancer, 15, 685. https://doi.org/10.1186/s12885-015-1672-4

Chicago Style (17th ed.) Citation

CE, Adkins, Nounou MI, Hye T, Mohammad AS, Terrell-Hall T, Mohan NK, Eldon MA, Hoch U, and Lockman PR. "NKTR-102 Efficacy Versus Irinotecan in a Mouse Model of Brain Metastases of Breast Cancer." BMC Cancer 15 (2015): 685. https://doi.org/10.1186/s12885-015-1672-4.

MLA (9th ed.) Citation

CE, Adkins, et al. "NKTR-102 Efficacy Versus Irinotecan in a Mouse Model of Brain Metastases of Breast Cancer." BMC Cancer, vol. 15, 2015, p. 685, https://doi.org/10.1186/s12885-015-1672-4.